The inquiry and report of the Senate Community Affairs References Committee which reviewed the out-of-pocket costs in Australian healthcare. Introduction Health expenditure occurs when money is spent on health goods and services. It occurs at different levels of government, as well as by non-government entities such as private health insurers and individual. This report discusses...

This audit assessed the effectiveness of the Therapeutic Goods Administration’s application of the Code of Good Manufacturing Practice for prescription medicines. Overall conclusion The Department of Health, through the TGA, administers the Australian regulatory framework for therapeutic goods, providing assurance to the community that prescription medicines, whether of Australian or overseas origin, are manufactured in...

The Trans Pacific Partnership Agreement has the potential to negatively impact the health of Australians by raising the cost of medicine and limiting the government's ability to regulate tobacco and alcohol, argues this policy brief based on publicly available and recently leaked negotiating documents. Executive summary The purpose of this policy brief is to inform...

The Pharmacy Guild of Australia claims that bringing forward reductions in the prices of prescription medicines will threaten the survival of local pharmacies.

Background: Older people often take a relatively high number of prescription medicines and experience a range of issues linked with these medicines. Older people admitted to hospital for an acute condition often experience changes to their medicines and as a result they may experience problems such as adverse medicine events. The number of older people...